These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7536012)

  • 1. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model.
    Singer GG; Carrera AC; Marshak-Rothstein A; Martínez C; Abbas AK
    Curr Opin Immunol; 1994 Dec; 6(6):913-20. PubMed ID: 7536012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
    Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
    J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
    Watanabe D; Suda T; Hashimoto H; Nagata S
    EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane.
    Cohen PL; Eisenberg RA
    Immunol Today; 1992 Nov; 13(11):427-8. PubMed ID: 1282318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas and Fas ligand: lpr and gld mutations.
    Nagata S; Suda T
    Immunol Today; 1995 Jan; 16(1):39-43. PubMed ID: 7533498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
    Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression and dysfunction of Fas antigen in MRL/MpJ-lpr/lpr murine ovary.
    Xu JP; Li X; Mori E; Guo MW; Mori T
    Zygote; 1998 Nov; 6(4):359-67. PubMed ID: 9921647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
    Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
    Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic basis of autoimmune disease in MRL-lpr/lpr mice.
    Shirai A; Klinman DM
    Int Rev Immunol; 1994; 11(3):179-92. PubMed ID: 7523550
    [No Abstract]   [Full Text] [Related]  

  • 13. The Fas death factor.
    Nagata S; Golstein P
    Science; 1995 Mar; 267(5203):1449-56. PubMed ID: 7533326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRL-lpr/lpr disease: theories meet Fas.
    Steinberg AD
    Semin Immunol; 1994 Feb; 6(1):55-69. PubMed ID: 7513194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do defects in the Fas-Fas ligand system cause autoimmunity?
    Suda T; Nagata S
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S97-101. PubMed ID: 9440553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.
    Famularo G; Nucera E; Marcellini S; De Simone C
    Med Hypotheses; 1999 Jul; 53(1):50-62. PubMed ID: 10499826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis.
    Waldner H; Sobel RA; Howard E; Kuchroo VK
    J Immunol; 1997 Oct; 159(7):3100-3. PubMed ID: 9317104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
    Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
    Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.